【ChiCTR2500104207】Randomized Controlled Trail: Medical Assessment and Response by Small-unmanned-aerial-system (MARS)
ChiCTR2500104207
结束
Small-unmanned-aerial-system
/
/
2025-06-12
/
/
NA
Randomized Controlled Trail: Medical Assessment and Response by Small-unmanned-aerial-system (MARS)
Medical Assessment and Response by Small-unmanned-aerial-system (MARS)
1. conduct a comprehensive patient assessment using drone when emergency, 2. validate if the TAM framework can also contribute to understanding public decision making with respect to the adoption of drones in medical response.
随机平行对照
其它
In this parallel group RCT, participants were randomly allocated into two groups: (1) non-injury control or (2) simulated acute ankle sprain in 1:1 ratio using a computer-generated sequence (block randomisation, block size = 4) stratified by prior drone experience (<10 vs. >=10 hours).
Single bind to research
/
/
64
/
2023-08-01
2024-11-30
/
Experience in emergency response；
请登录查看participants younger than 14 years old, which do not meet the Hong Kong Drone Law requirement；
请登录查看Caritas Institute of Higher Education
/
Caritas Institute of Higher Education的其他临床试验
- Randomized Controlled Trail: Medical Assessment and Response by Small-unmanned-aerial-system (MARS)
- Clinical Training Dosage of Robotic Exoskeleton Assisted Gait Training for Improvement of Gait Parameters, Walking Performance, Balance and Health-related Benefits in Patients with Chronic Stroke: a Randomized Control Trial
Hong Kong Metropolitan University的其他临床试验
- Effectiveness of an immersive virtual reality (VR)-based mindfulness intervention (MI) to reduce depressive symptoms in patients with autoimmune arthritis (AA): a randomized control trial (RCT)
- Randomized Controlled Trail: Medical Assessment and Response by Small-unmanned-aerial-system (MARS)
- Efficacy of Online Gamified Pain Management for Adults with Chronic Pain in Mainland China: A Randomized Control Trial
- Acute and chronic musculoskeletal pain situations among adults and their educational requirements on pain in mainland China: an exploratory study
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
Small-unmanned-aerial-system相关临床试验
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
同适应症药物临床试验
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04